Premium
Monte Rosa Therapeutics Inc (GLUE)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| New Enterprise Associates, Inc. | Institution | 7 692 298 | 9,11% | US$ 136,46M | 2026-03-31 |
| New Enterprise Associates 17, L.P. | Institution | 7 692 298 | 9,11% | US$ 136,46M | 2026-03-17 |
| T. Rowe Price Group, Inc. | Institution | 6 720 188 | 7,95% | US$ 119,22M | 2026-03-31 |
| Dimension Capital I, L.P. | Institution | 5 663 265 | 6,70% | US$ 100,47M | 2026-03-31 |
| Dimension Capital Partners, LLC | Institution | 5 663 265 | 6,70% | US$ 100,47M | 2026-03-31 |
| BlackRock, Inc. | Institution | 5 637 684 | 6,67% | US$ 100,01M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 4 622 151 | 5,47% | US$ 82,00M | 2026-03-31 |
| BVF Partners L.P. | Institution | 4 460 886 | 5,28% | US$ 79,14M | 2026-03-31 |
| Baker Bros. Advisors LP | Institution | 4 345 736 | 5,14% | US$ 77,09M | 2026-03-31 |
| Suvretta Capital Management, LLC | Institution | 4 226 809 | 5,00% | US$ 74,98M | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 3 603 465 | 4,27% | US$ 63,93M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 3 353 980 | 3,97% | US$ 59,50M | 2026-03-31 |
| Braidwell LP | Institution | 3 206 574 | 3,80% | US$ 56,88M | 2026-03-31 |
| Versant Venture Management, LLC | Institution | 3 180 780 | 3,77% | US$ 56,43M | 2026-03-31 |
| Averill Master Fund, Ltd. | Institution | 3 147 448 | 3,73% | US$ 55,84M | 2025-04-09 |
| Vanguard Capital Management, LLC | Institution | 3 100 245 | 3,67% | US$ 55,00M | 2026-03-31 |
| American Century Investment Management Inc | Institution | 2 809 647 | 3,33% | US$ 49,84M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 2 382 732 | 2,82% | US$ 42,27M | 2026-03-31 |
| Versant Venture Capital VI | Institution | 2 236 708 | 2,65% | US$ 39,68M | 2026-01-08 |
| TCG Crossover Fund II, L.P. | Institution | 2 213 853 | 2,62% | US$ 39,27M | 2025-10-10 |
| TCG Crossover Fund III, L.P. | Institution | 2 213 852 | 2,62% | US$ 39,27M | 2025-10-10 |
| Silverarc Capital Management, LLC | Institution | 2 002 040 | 2,37% | US$ 35,52M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 1 742 806 | 2,06% | US$ 30,92M | 2026-03-31 |
| Aisling Capital Management LP | Institution | 1 555 664 | 1,84% | US$ 27,60M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 540 812 | 1,82% | US$ 27,33M | 2026-03-31 |
| Marshall Wace LLP | Institution | 1 433 152 | 1,70% | US$ 25,42M | 2026-03-31 |
| HBM Partners Ltd. | Institution | 1 407 040 | 1,67% | US$ 24,96M | 2024-12-31 |
| Bellevue Asset Management AG | Institution | 1 250 000 | 1,48% | US$ 22,18M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 1 176 928 | 1,39% | US$ 20,88M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 1 041 372 | 1,23% | US$ 18,47M | 2026-03-31 |
| FMR LLC | Institution | 1 024 304 | 1,21% | US$ 18,17M | 2026-03-31 |
| Versant Vantage I, L.P. | Institution | 1 013 361 | 1,20% | US$ 17,98M | 2026-01-08 |
| Frazier Life Sciences Management, LP | Institution | 1 000 000 | 1,18% | US$ 17,74M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 891 158 | 1,05% | US$ 15,81M | 2026-03-31 |
| Dimension Management, L.P. | Institution | 850 500 | 1,01% | US$ 15,09M | 2026-03-31 |
| Dimension Capital II, L.P. | Institution | 850 500 | 1,01% | US$ 15,09M | 2026-03-31 |
| Bridgeway Capital Management, LLC | Institution | 834 096 | 0,99% | US$ 14,80M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 826 624 | 0,98% | US$ 14,66M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 685 926 | 0,81% | US$ 12,17M | 2026-03-31 |
| GV Management Company, LLC | Institution | 684 275 | 0,81% | US$ 12,14M | 2026-03-31 |
| Nantahala Capital Management, LLC | Institution | 651 993 | 0,77% | US$ 11,57M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
